Northrop Grumman combines record backlog, raised 2026 guidance and expanding demand for strategic deterrence, missile defense and solid-rocket-motor capacity. The $104.7 billion backlog provides substantial revenue visibility, while more than $3 billion of newly announced missile-interceptor framework agreements and full-rate IBCS production reinforce the growth runway. The principal counterweight is execution risk on large, technically complex programs—especially B-21 and Sentinel—where schedule slippage, inflation or revised cost estimates can produce material charges. On balance, durable demand and backlog support a Buy rating, but the position should be monitored against guidance delivery and program-cost milestones.